Jack Anders - 17 Dec 2021 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Reporting relationship: SVP, Finance and Principal Accounting Officer
Issuer ticker: RVMD
Reported as of: 17 Dec 2021
Net transaction value: -$4,150
SEC form: 4
Accepted by SEC: 21 Dec 2021, 15:34:15 UTC
Prior SEC filing: 21 Sep 2021
Next SEC filing: 03 Mar 2022
Source filing: View source filing
Reporting owner signature: /s/ Jack Anders

Filing notes and source

Key filing fact

Jack Anders filed Form 4 for Revolution Medicines, Inc. (RVMD) on 21 Dec 2021.

Key facts

This page summarizes Jack Anders's Form 4 filing for Revolution Medicines, Inc. (RVMD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Dec 2021, 15:34.

Change

Previous filing in this sequence was filed on 21 Sep 2021.
Current net transaction value: -$4,150.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RVMD transaction

Common Stock

Sale

Transaction value: $4,150
Shares: -170
Change %: -2%
Price: $24.41
Shares after: 8,434
Date: 17 Dec 2021
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Pursuant to an automatic sell-to-cover imposed by the terms of the initial grant of the restricted stock units ("RSUs") awards, the shares were sold upon the vesting of the RSUs solely to cover applicable withholding taxes.

Footnote F2

Includes 412 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2021.

Footnote F3

Includes 6,013 RSUs.

SEC remarks

SVP, Finance and Principal Accounting Officer